Cell Image 1

Discovering the
future of medicine

Wistar Science: Bold. Imaginative. Inspired.

Learn More

Recent Press Releases

View all ›

International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands 

Synthetic DNA Technology Applied as a Novel Strategy for Delivery of Anti-HIV Antibodies

Wistar Institute Researcher Awarded American Cancer Society Research Professorship

Our Centers

Maureen and lab

Cancer Center

Wistar is a National Cancer Institute Cancer Center in basic research and has held this designation since 1972.
David and Ami_In the Lab1

Vaccine & Immunotherapy Center

Improving health around the globe by creating and advancing vaccines and immunotherapies.

Upcoming events

View all events ›

Scientific Seminar

Vaccines & Immune Therapeutics: "Vaccine Confidence-Fact, Fiction, Perception"

Scientific Seminar

Philadelphia Drug Discovery Forum: Biacore User Day

Special Event

Women & Science: Pushing the Envelope in Cancer Immunotherapy

125 Years of Discovery

View full timeline ›
Stanley Plotkin

Rubella Vaccine

Stanley Plotkin, M.D., and Koprowski developed the vaccine of choice against rubella, also known as German measles. Rubella led to various birth defects including blindness, deafness and severe mental retardation as well as miscarriages and stillbirths across Europe and the U.S. in the 1960s.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today